P.P.DamierP.P. i inni, Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort, „European Journal of Neurology”, 15 (7), 2008, s. 643–648, DOI: 10.1111/j.1468-1331.2008.02165.x, PMID: 18582341(ang.).
Joaquim J.J.J.FerreiraJoaquim J.J.J. i inni, Effects of nebicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity, and motor fluctuations in patients with Parkinson disease, „Clinical Neuropharmacology”, 31 (1), 2008, s. 2–18, DOI: 10.1097/wnf.0b013e3180645cb0, PMID: 18303486(ang.).
P.P.DamierP.P. i inni, Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort, „European Journal of Neurology”, 15 (7), 2008, s. 643–648, DOI: 10.1111/j.1468-1331.2008.02165.x, PMID: 18582341(ang.).
Joaquim J.J.J.FerreiraJoaquim J.J.J. i inni, Effects of nebicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity, and motor fluctuations in patients with Parkinson disease, „Clinical Neuropharmacology”, 31 (1), 2008, s. 2–18, DOI: 10.1097/wnf.0b013e3180645cb0, PMID: 18303486(ang.).